- US-listed companies
- Atara Biotherapeutics, Inc.
- Balance sheet
Atara Biotherapeutics, Inc. (ATRA) Balance sheet
Market cap
$27.72M
P/E ratio
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 22 | 24 | 48 | 79 | 62 | 76 | 202 | 107 | 93 | 26 | 25 |
| Marketable securities, current | 164 | 297 | 208 | 87 | 249 | 185 | 300 | 265 | 150 | 26 | 17 |
| Total cash & short-term investments | 186 | 320 | 256 | 166 | 311 | 261 | 502 | 372 | 243 | 52 | 43 |
| Accounts receivable, net | - | - | - | - | - | - | 1 | 1 | 40 | 34 | 1 |
| Inventories | - | - | - | - | - | - | - | - | 2 | 10 | 11 |
| Total current assets | 106 | 325 | 261 | 172 | 321 | 273 | 523 | 385 | 295 | 102 | 65 |
| Property, plant and equipment, net | 0 | 0 | 3 | 44 | 69 | 54 | 51 | 54 | 6 | 4 | 1 |
| Total non-current assets | 0 | 0 | 3 | 46 | 70 | 70 | 65 | 84 | 81 | 64 | 44 |
| Total assets | 106 | 325 | 264 | 218 | 392 | 343 | 588 | 468 | 376 | 166 | 109 |
| Accounts payable | 0 | 1 | 3 | 15 | 4 | 8 | 7 | 17 | 7 | 4 | 4 |
| Total current liabilities | 3 | 10 | 10 | 28 | 40 | 37 | 83 | 106 | 79 | 142 | 135 |
| Total non-current liabilities | 0 | 0 | 1 | 12 | 13 | 15 | 43 | 83 | 171 | 123 | 72 |
| Total liabilities | 3 | 10 | 10 | 40 | 53 | 52 | 126 | 189 | 250 | 265 | 206 |
| Common stock and paid-in capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained earnings | -41 | -98 | -177 | -297 | -527 | -818 | -1,125 | -1,465 | -1,693 | -1,969 | -2,055 |
| Stockholders' equity | 103 | 315 | 254 | 178 | 339 | 291 | 462 | 280 | 127 | -99 | -97 |
| Working capital | - | - | - | - | - | - | - | - |